Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.
about
Transcriptome Profiling of Patient-Specific Human iPSC-Cardiomyocytes Predicts Individual Drug Safety and Efficacy Responses In Vitro.iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.Optical-flow based non-invasive analysis of cardiomyocyte contractility.Functional correction of dystrophin actin binding domain mutations by genome editing.Operationalizing Precision Cardiovascular Medicine: Three Innovations.Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.Personalized Management of Cardiovascular Disorders.Inspiration from heart development: Biomimetic development of functional human cardiac organoids.The Impact of CRISPR/Cas9 Technology on Cardiac Research: From Disease Modelling to Therapeutic Approaches.Regenerative Medicine: lessons from Mother Nature.Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.Genome Editing in Cardiovascular Biology.Modularized Extracellular Vesicles: The Dawn of Prospective Personalized and Precision Medicine.Mechanical stretch induced transcriptomic profiles in cardiac myocytes.Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies.Patient-Specific Induced Pluripotent Stem Cell-Based Disease Model for Pathogenesis Studies and Clinical Pharmacotherapy.Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug DiscoveryFreezing Responses in DMSO-Based Cryopreservation of Human iPS Cells: Aggregates Versus Single Cells
P2860
Q30826981-9842CD05-46E4-4152-A9D8-C5C215CC8691Q37297762-3A6032FE-68B3-43A1-A4A0-18F04F03C4ADQ38653210-231DF6E4-33B1-4BA6-B09A-8C17A47F1D0BQ39126523-625BD8AB-D126-46EA-9BC8-C4B456744E8DQ39441598-13FFF16B-07C1-4222-8291-9BB23B37E4B3Q41607212-6906BFC4-B59D-473F-9F13-F9583B0AC14CQ42162721-25BCBD33-D94D-4C5E-9AC4-709415CA25D6Q42359562-C8E254C6-A4F0-4746-A057-B8D527F25A0BQ47442360-130C6546-88C5-4CEF-ADC4-BD74C5F43BEEQ47690029-F63A87B1-50B9-4BCB-806A-0B41650414E3Q47819879-1C214742-8691-4031-AF85-02F96F191F03Q49432567-0C973E10-ADDF-4241-8F61-C71E9E268FFEQ50474217-9EBE8C95-B7AC-4F32-BD8E-CED8B53E4E60Q51417867-37C9AD15-B751-4EF0-A3CA-F91009FCCDF5Q52427027-9562A726-3F76-490C-BFAB-825E277EE613Q52605943-232F0F8F-89C1-475F-B58C-5C9417D424A8Q52651221-7905E010-5763-4D58-972B-3BD632FEC485Q54941216-C904E18A-5C36-4E5C-805C-53C67D5D7296Q54996455-8E0E35DF-1BBA-4A87-90B3-4F06FCAAF083Q57072496-A1529E1D-0057-42DE-ADC8-7F9CFB4FCC6BQ57092456-A7472E49-B96C-4B95-9480-B1E3462CD6E5
P2860
Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Human Induced Pluripotent Stem ...... ision Cardiovascular Medicine.
@en
type
label
Human Induced Pluripotent Stem ...... ision Cardiovascular Medicine.
@en
prefLabel
Human Induced Pluripotent Stem ...... ision Cardiovascular Medicine.
@en
P2093
P2860
P1476
Human Induced Pluripotent Stem ...... cision Cardiovascular Medicine
@en
P2093
Elena Matsa
John H Ahrens
Joseph C Wu
P2860
P304
P356
10.1152/PHYSREV.00036.2015
P50
P577
2016-07-01T00:00:00Z